Chargement en cours...
Calreticulin arms NK cells against leukemia
Calreticulin (CALR) exposed on the surface of cancer cells succumbing to therapy delivers robust phagocytic signals that support the activation of adaptive anticancer immune responses. Recent data from our group demonstrate that spontaneous CARL exposure on leukemic blasts also supports innate antic...
Enregistré dans:
| Publié dans: | Oncoimmunology |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959451/ https://ncbi.nlm.nih.gov/pubmed/32002282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1671763 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|